Login
← Go Back
Alivus Life Sciences
ALIVUS · Pharma > Pharmaceuticals & Drugs · Chairman: Glenn Saldanha · MD: Yasir Rawjee · Listing date: Aug. 7, 2021 · Employees: 1537 · Mumbai · http://www.glenmarklifesciences.com
Stock Price vs Company Growth
1d
1.6%
1w
4.7%
1m
8.6%
3m
8.8%
6m
1.8%
1y
3.4%
all
9.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 985 1.6%
830
999
Company Overview
Sales
2,512 Cr
Growth: 8.3%
Profit after Tax
544 Cr
Growth: 2.5%
Mid Cap
12,087 Cr
P/E: 22.3x
Industry P/E: 27.1x
Fundamentals
Sales (Cr) ₹ 2,512
Growth 8.3%
EBITDA 31.1%
P/S 4.8x
Dividend 0.0%
P/E 22.3x
Book Value ₹ 262
PEG Ratio 2.7x
ROE 18.1%
P/B 3.8x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is in the business of making high-quality drugs by unlocking the possibilities of science.Awards, accreditations and recognitions2015: Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility.
Belongs to (13 Indices) view more
Investors (7)
icici.pr...
nirma
santhosh...
Followers (2)
atharav
varsha96